Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKCβ
- 1 June 2003
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (11) , 1857-1859
- https://doi.org/10.1016/s0960-894x(03)00286-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Strategies for the synthesis of N-(azacycloalkyl)bisindolylmaleimides: selective inhibitors of PKCβTetrahedron, 2003
- Role of protein kinase C isozymes in cellular functions and pathological conditions.Folia Pharmacologica Japonica, 2002
- Protein kinase C inhibitors as novel anticancer drugsExpert Opinion on Investigational Drugs, 2001
- Protein Kinase C as a Drug Target Implications for Drug or Diet Prevention and Treatment of CancerCurrent Drug Targets, 2000
- Protein kinase C as a target for new anti-cancer agentsJournal of Oncology Pharmacy Practice, 1999
- Macrocyclic Bisindolylmaleimides: Synthesis by Inter- and Intramolecular AlkylationThe Journal of Organic Chemistry, 1998
- Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β InhibitorScience, 1996
- (S)-13-[(Dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16,21-dimetheno- 1H,13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-dione (LY333531) and Related Analogues: Isozyme Selective Inhibitors of Protein Kinase CβJournal of Medicinal Chemistry, 1996
- A convenient synthesis of bisindolylmaleimidesTetrahedron Letters, 1993
- A calcium/calmodulin-dependent protein kinase from mammalian brain that phosphorylates Synapsin I: partial purification and characterizationJournal of Neuroscience, 1983